Overview

Safety and Tolerability of Dabigatran Etexilate Solution in Children 1 to < 12 Years of Age

Status:
Completed

Trial end date:
2016-02-01

Target enrollment:

Participant gender:

Summary

To investigate the safety and tolerability of dabigatran etexilate solution in children and to obtain preliminary pharmacokinetic/pharmacodynamic data

Phase:

Phase 2

Details

Lead Sponsor:

Boehringer Ingelheim

Treatments:

Dabigatran